Back to results
US 2001/0037025 A1Published application
New compounds, their preparation and use
OwnerAnthony Murray, John Bondo Hanseninventors
Life of this patent
Estimating the term…
Abstract
The present invention provides novel compounds of formula I 1 wherein R1, R2, W, Z and R5 to R9 are defined more fully in the description. The compounds are useful in the treatment of ailments and disorders where a reduction of the blood glucose is beneficial, such as diabetes.
Claims13
A compound of formula I
- 12
- wherein
- R1 and R2 are independently hydrogen or C1-6 alkyl;
- W is
- 13
- , O, N—R3, S, SO or SO2 wherein R3 and R4 are independently hydrogen or C1-6 alkyl;
- R5 is hydrogen, C1-6 alkyl, halogen, OR11, SR11, OCOR11, NH2, NHR11, NR11R12, NHCOR11, NR11—COR12 where R11 and R12 are independently C1-6 alkyl, phenyl or alkyl phenyl;
- R6 is hydrogen, or taken together with R7 forms a double bond, or taken together with R7 is methylene to form a cyclopropyl ring;
- R7 is hydrogen, or taken together with R6 forms a double bond, or taken together with R6 is methylene to form a cyclopropyl ring, or taken together with R9 forms a double bond, or taken together with R9 is methylene to form a cyclopropyl ring;
- R8 is hydrogen, or taken together with R9 forms a double bond, or taken together with R9 is methylene to form a cyclopropyl ring
- R9 is hydrogen, hydroxy, OR13, OCOR13, or taken together with R7 forms a double bond, or taken together with R7 is methylene to form a cyclopropyl ring, or taken together with R8 forms a double bond, or taken together with R8 is methylene to form a cyclopropyl ring, where R13 is C1-6 alkyl, phenyl or alkyl phenyl;
- Z is X—Y—R10, wherein X is a valence bond, phenyl or pyridyl, optionally substituted with C1-3 alkyl, halogen, hydroxy, C1-3 alkoxy, C1-3 acyloxy, C1-3 alkyl halide, thiol, C1-3 substituted thiol, Y is C1-6-alkyl, C2-6 alkenyl or C2-6 alkynyl and R10 is CO2H, tetrazole, PO3H, SO3H, CO2R15, CONR16R17, CH2OH, CHO, CH2OR18, CH(OR19)2, HC(OR20O), COR21, CR20(OR19)2, CR21(OR20O), wherein R15 is C1-6 alkyl, phenyl or alkyl phenyl;
- or
- Z is ═Y—R10, wherein Y is CR14, CR14—C1-6 alkyl, CR14phenyl, CR14pyridyl, CR14C1-3 alkylaryl, CR14—C2-5 alkenyl or CR14—C2-5 alkynyl, wherein R14 is H or C1-3 alkyl and R10 is CO2H, tetrazole, PO3H, SO3H, CO2R15, CONR16R17, CH2OH, CHO, CH2OR18, CH(OR19)2, HC(OR20O), COR21, CR20(OR19)2, CR21(OR20O), wherein R15 is C1-6 alkyl, phenyl or alkyl phenyl;
- R16 and R17 are independently hydrogen, C1-6-alkyl, C5-8 cycloalkyl, phenyl or C1-6-alkyl phenyl;
- R18 is C1-6-alkyl, phenyl or C1-6-alkyl phenyl;
- R19 is C1-6 alkyl;
- R20 is C2-4 alkyl;
- R21 is C1-6 alkyl phenyl or C3-6 cycloalkyl;
- or a salt thereof with a pharmaceutically acceptable acid or base, or any optical isomer or mixture of optical isomers, or any tautomeric forms.
17 more elements
Dependencies are inferred from the claim text.